Chris Nevala

GI medical oncologist at U of Utah

[Pashtoon Kasi MD, MS @pashtoonkasi]

@gabe_a_brooks @ASCO @ChiaraCrem1 @OncoAlert #ASCO22 worth noting some recent real 🌎 🇺🇸 data on patients with #colorectalcancer who got

EGFR⛔️
🆚
VEGF⛔️

It crosses 42 months!

Sequencing upfront is relevant. Not just in terms of biologics; but also:

Triplet
🆚
Doublet

#CRCSM
Good derm followup.
💡 💊 Amiloride.

[Journal of the @NCCN @JNCCN]

Treatment Trends and Clinical Outcomes of Left-Sided RAS/RAF Wild-Type Metastatic #ColorectalCancer in the United States: https://t.co/JwyroWRiOd by @GarridoLagunaMD @ChrisNevala @DTrunkMD and colleagues at @huntsmancancer
#CRCSM #hsronc

[Journal of the @NCCN @JNCCN]

Publication Alert: Clinical Activity of #Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to #Entrectinib: https://t.co/WNekUHqT6j @VaiaFlorou @GarridoLagunaMD @ChrisNevala @huntsmancancer #hncsm #NTRK #NTRKfusion

[Utah IM CMRs @UtahIMCMRs]

👏💪👊 Strong work Dr. Laura Miotke PGY-3 and rising VA #CRQS on her work differentiating recurrent vs. de-novo pancreatic cancer with mentorship from Dr @GarridoLagunaMD @huntsmancancer

https://t.co/IVvEr5qyzN

#MedicineElevatedResearch #WIM #UtahWIM